BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stroffolini T, Sagnelli E, Sagnelli C, Russello M, De Luca M, Rosina F, Cacopardo B, Brancaccio G, Furlan C, Gaeta GB, Licata A, Almasio PL;  behalf of EPACRON study group. Hepatitis delta infection in Italian patients: towards the end of the story? Infection. 2017;45:277-281. [PMID: 27817147 DOI: 10.1007/s15010-016-0956-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Caviglia GP, Martini S, Ciancio A, Niro GA, Olivero A, Fontana R, Tandoi F, Rosso C, Romagnoli R, Saracco GM, Smedile A, Rizzetto M. The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease. J Adv Res 2021;33:183-7. [PMID: 34603788 DOI: 10.1016/j.jare.2021.02.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hercun J, Koh C, Heller T. Hepatitis Delta. Gastroenterology Clinics of North America 2020;49:239-52. [DOI: 10.1016/j.gtc.2020.01.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Mentha N, Clément S, Negro F, Alfaiate D. A review on hepatitis D: From virology to new therapies. J Adv Res 2019;17:3-15. [PMID: 31193285 DOI: 10.1016/j.jare.2019.03.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 12.0] [Reference Citation Analysis]
4 Stroffolini T, Ciancio A, Furlan C, Vinci M, Niro GA, Russello M, Colloredo G, Morisco F, Coppola N, Babudieri S, Ferrigno L, Sagnelli C, Sagnelli E; Collaborating group. Chronic hepatitis B virus infection in Italy during the twenty-first century: an updated survey in 2019. Eur J Clin Microbiol Infect Dis 2021;40:607-14. [PMID: 33029767 DOI: 10.1007/s10096-020-04065-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Stroffolini T, Morisco F, Ferrigno L, Pontillo G, Iantosca G, Cossiga V, Crateri S, Tosti ME; SEIEVA collaborating group. Acute Delta Hepatitis in Italy spanning three decades (1991-2019): Evidence for the effectiveness of the hepatitis B vaccination campaign. J Viral Hepat 2021. [PMID: 34585819 DOI: 10.1111/jvh.13620] [Reference Citation Analysis]
6 Rizzetto M, Hamid S, Negro F. The changing context of hepatitis D. J Hepatol. 2021;74:1200-1211. [PMID: 33484770 DOI: 10.1016/j.jhep.2021.01.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 11.0] [Reference Citation Analysis]
7 Sagnelli C, Sagnelli E. Towards the worldwide eradication of hepatitis B virus infection: A combination of prophylactic and therapeutic factors. World J Clin Infect Dis 2019; 9(2): 11-22 [DOI: 10.5495/wjcid.v9.i2.11] [Cited by in CrossRef: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Aguilera A, Trastoy R, Rodríguez-Calviño J, Manso T, de Mendoza C, Soriano V. Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain. Eur J Gastroenterol Hepatol 2018;30:1060-2. [PMID: 29742524 DOI: 10.1097/MEG.0000000000001163] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Sahin A, Gurocak S, Tunc N, Demirel U, Poyrazoglu OK, Akbulut H, Yalniz M, Toraman ZA, Bahcecioglu IH. Anti-HDV seroprevalance among patients with previous HBV infection. North Clin Istanb 2018;5:132-8. [PMID: 30374479 DOI: 10.14744/nci.2018.01328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Chauhan R, Lingala S, Gadiparthi C, Lahiri N, Mohanty SR, Wu J, Michalak TI, Satapathy SK. Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management. World J Hepatol 2018; 10(3): 352-370 [PMID: 29599899 DOI: 10.4254/wjh.v10.i3.352] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
11 Coppola N, Alessio L, Onorato L, Sagnelli C, Sagnelli E, Pisaturo M. HDV infection in immigrant populations. J Med Virol 2019;91:2049-58. [PMID: 31429940 DOI: 10.1002/jmv.25570] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Sagnelli C, Pisaturo M, Calò F, Martini S, Sagnelli E, Coppola N. Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention. World J Gastroenterol 2019; 25(26): 3299-3312 [PMID: 31341357 DOI: 10.3748/wjg.v25.i26.3299] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
13 Ferrarese A, Sciarrone S, Gambato M, Germani G, Senzolo M, Boccagni P, Cillo U, Burra P, Russo FP. Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting. Aliment Pharmacol Ther 2020;51:482-3. [PMID: 31990393 DOI: 10.1111/apt.15619] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Sagnelli C, Pisaturo M, Curatolo C, Codella AV, Coppola N, Sagnelli E. Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic. World J Gastroenterol 2021; 27(42): 7271-7284 [PMID: 34876788 DOI: 10.3748/wjg.v27.i42.7271] [Reference Citation Analysis]
15 Brancaccio G, Gaeta GB. Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting-authors' reply. Aliment Pharmacol Ther 2020;51:484. [PMID: 31990394 DOI: 10.1111/apt.15625] [Reference Citation Analysis]
16 Couto I, Victoria M, Veloso VG, Rodrigues L, Grinsztejn B, Lacerda M, Victoria F, Perazzo H. Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection. PLoS One. 2017;12:e0174453. [PMID: 28329027 DOI: 10.1371/journal.pone.0174453] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
17 Stroffolini T, Ciancio A, Furlan C, Vinci M, Fontana R, Russello M, Colloredo G, Morisco F, Coppola N, Babudieri S, Ferrigno L, Sagnelli C, Sagnelli E. Migratory flow and hepatitis delta infection in Italy: A new challenge at the beginning of the third millennium. J Viral Hepat 2020;27:941-7. [PMID: 32338810 DOI: 10.1111/jvh.13310] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Jachs M, Binter T, Schmidbauer C, Hartl L, Strasser M, Laferl H, Hametner-Schreil S, Lindorfer A, Dax K, Stauber RE, Kessler HH, Bernhofer S, Maieron A, Loacker L, Bota S, Santonja I, Munda P, Mandorfer M, Peck-Radosavljevic M, Holzmann H, Gschwantler M, Zoller H, Ferenci P, Reiberger T. Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosis. United European Gastroenterol J 2021;9:1119-27. [PMID: 34873866 DOI: 10.1002/ueg2.12163] [Reference Citation Analysis]
19 Rocco C, Bonavolta R, Vallefuoco L, Braschi U, Sorrentino R, Terracciano D, Portella G. Comparison of anti-hepatitis D virus (HDV) ETI-AB-DELTAK-2 assay and the novel LIAISON® XL MUREX anti-HDV assay in the diagnosis of HDV infection. Diagn Microbiol Infect Dis 2019;95:114873. [PMID: 31473034 DOI: 10.1016/j.diagmicrobio.2019.114873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Ricco G, Popa DC, Cavallone D, Iacob S, Salvati A, Tabacelia D, Oliveri F, Mascolo G, Bonino F, Yuan Q, Xia NS, Gheorghe L, Brunetto MR. Quantification of serum markers of hepatitis B (HBV) and Delta virus (HDV) infections in patients with chronic HDV infection. J Viral Hepat 2018;25:911-9. [PMID: 29577518 DOI: 10.1111/jvh.12895] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
21 Niro GA, Ferro A, Cicerchia F, Brascugli I, Durazzo M. Hepatitis delta virus: From infection to new therapeutic strategies. World J Gastroenterol 2021; 27(24): 3530-3542 [PMID: 34239267 DOI: 10.3748/wjg.v27.i24.3530] [Reference Citation Analysis]